| Phase 1/2 |
| NCT07410494 |
Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced… |
Cancer |
Recruiting |
2026-02-18 |
| NCT07410676 |
EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors |
Cancer |
Recruiting |
2026-02-18 |
| NCT06213636 |
Fourth-gen CAR T Cells Targeting CD19/CD22 for Highly Resistant B-cell Lymphoma/Leukemia… |
Acute Lymphoblastic Leukemia, Adult B-Cell |
Recruiting |
2025-08-06 |
| NCT07067255 |
Sequential CD146 and GPC3 CAR-T Cell Therapy in Advanced Ovarian Cancer |
Ovarian Cancer |
Recruiting |
2025-07-16 |
| NCT07066982 |
Sequential Infusion of CD146-Targeted and HER2-Targeted CAR T Cells in Patients With… |
Sarcoma |
Recruiting |
2025-07-15 |
| NCT07066995 |
Mesothelin and Claudin 18.2 Dual-Target CAR-T Therapy in Advanced Pancreatic Cancer |
Pancreatic Cancer |
Recruiting |
2025-07-15 |
| NCT07032129 |
Sequential CAR-T Cells Targeting BCMA/GPRC5D in Patients With Relapsed/ Refractory… |
Multiple Myeloma |
Recruiting |
2025-06-22 |
| NCT06420063 |
Sequential CAR-T Cells Targeting CD33/CD123 in Patients With Acute Myelocytic Leukemia AML |
AML |
Recruiting |
2024-11-12 |
| NCT06420076 |
Sequential CAR-T Cells Therapy for CD5/CD7 Positive T-cell Acute Lymphoblastic Leukemia… |
T Cell Lymphoma |
Recruiting |
2024-11-12 |
| NCT06532799 |
TIL Therapy Combined With Pembrolizumab for Advanced or Metastatic Refractory Stomach and… |
Stomach Cancer |
Recruiting |
2024-11-12 |
| NCT06532812 |
TIL Gean Therapy Combined With Immunotherapy for Advanced or Metastatic Refractory Breast… |
Breast Cancer |
Recruiting |
2024-11-12 |
| NCT06399107 |
Investigation Into the Use of BAH243 Lentiviral Vector for Gene Therapy in Treating… |
Sickle Cell Disease |
Recruiting |
2024-11-05 |
| NCT06428188 |
Sequential CAR-T Cells Targeting BCMA/CD19 in Patients With Relapsed/ Refractory… |
Autoimmune Diseases |
Recruiting |
2024-11-05 |
| NCT06530303 |
Biological Tumor Infiltrating Lymphocytes Therapy With Immunotherapy for Colon and Rectum… |
Colorectal Cancer |
Recruiting |
2024-11-05 |
| NCT06640582 |
TIL Therapy Combined With Pembrolizumab for Advanced Brain Cancer Including Gliomas and… |
Brain Tumor |
Recruiting |
2024-11-05 |
| NCT06350110 |
Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus… |
Systemic Lupus Erythematosus |
Recruiting |
2024-10-15 |
| NCT06538012 |
TIL Therapy Combined With Pembrolizumab for Advanced or Metastatic Refractory Lung Cancer |
Lung Cancer |
Recruiting |
2024-10-15 |